Abstract
Introduction: Thrombopoietin receptor agonists (TPO-RAs) are a reliable second-line immune thrombocytopenia (ITP) treatment. Despite an increase in us......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
